Accessibility Menu
Itoco logo

Itoco(OTC) ITMC

Market Cap$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)-100%
5 Year-100%
1 Year-99%
1 Month-99%
$0.00
+0.00%
+0.00Today
Itoco last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-27
Itoco stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99%USD 0.002026-07-08
1 month-99%USD 0.002026-06-25
3 month-99.5%USD 0.002026-04-28
Year to date-99%USD 0.002025-12-30
1 year-99%USD 0.002025-07-23
3 year-99.99%USD 0.012023-07-27
5 year-100%USD 0.222021-07-28
Since inception-100%USD 870.012010-01-04

Itoco Financials at a Glance

Market Cap

$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.87M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-32.06 (Low)

Price

$0.00

Volume

56,300

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.09

Estimated Earnings Date

N/A

ITMC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Itoco

Itoco Inc. is a biotechnology company based in Reno, Nevada, specializing in the complete lifecycle of medical cannabis products. The firm manages everything from raw material preparation to manufacturing and market delivery, positioning itself as a key player in the healthcare sector.

Products and Services
  • Complete lifecycle management of medical cannabis products
  • Manufacturing and distribution of cannabis-based solutions
  • Research and development in cannabis applications
Growth Outlook
  • Significant market potential in the expanding medical cannabis industry
  • Increased consumer demand for cannabis products projected over the next five years
  • Strategic initiatives aimed at enhancing operational efficiency and product offerings
Financial Highlights
  • Recent quarterly net income of -$1,127,544, reflecting ongoing operational challenges
  • Trailing twelve months (TTM) revenue remains at $0, indicating a need for revenue generation strategies
  • Current liabilities exceed total assets, highlighting financial leverage concerns
Itoco Inc. operates in a rapidly evolving industry, with the medical cannabis market expected to grow significantly in the coming years. The company's focus on the complete lifecycle of cannabis products positions it well to capitalize on this trend. However, recent financial data indicates challenges, including a net income loss and zero revenue over the trailing twelve months. The current liabilities surpass total assets, suggesting a need for careful financial management. Investors may find the company's strategic initiatives and market potential worth monitoring as Itoco Inc. navigates its path forward in the competitive biotechnology landscape.
AI Generated • Jul 18, 2026

Industry

Pharmaceuticals

CEO

Michael Anthony Paul

Headquarters

Reno, NV 89501, US

ITMC Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

199.43%

Return on Capital

N/A

Return on Assets

-133.49%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

428.21M

Volume

56.30K

Avg. Volume

41.34K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$919.00K

EBITDA

-$1.66M

Operating Cash Flow

$2.97K

Capital Expenditure

$0.00

Free Cash Flow

$2.97K

Cash & ST Invst.

$2.00

Total Debt

$228.40K

Itoco Performance Analysis

Itoco annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
Itoco sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-31N/A
Q22023-06-30N/A
Q32023-09-30N/A
Q42023-12-31N/A
Itoco annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.00N/A
20222022-12-31USD -0.014400.0%
20232023-12-31USD -0.01-15.6%
Itoco sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-3150.0%
Q22023-06-3016.7%
Q32023-09-30-10.0%
Q42023-12-31-290.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$8.51

N/A

Employees

47

N/A

Net Income

-$1.13M

-169.2%

EBITDA

-$1.08M

-197.8%

Quarterly Fundamentals

Name
Q4 2023YOY CHG

Total Cash

$2.00

-99.9%

Total Debt

$228.40K

-57.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$228.40K

-57.6%

Return on Assets

-1.33%

N/A

Return on Invested Capital

3.63%

N/A

Free Cash Flow

$3.07K

+150.2%

Operating Cash Flow

$3.07K

+150.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNLKQGeneLink, Inc.
$0.00+0.00%
VFRMVeritas Farms, Inc.
$0.00+0.00%
ENDVEndonovo Therapeutics, Inc.
$0.00+0.00%
DECNDecision Diagnostics Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About ITMC

What is the current price of Itoco?

Itoco is trading at $0.00 per share.

What is the 52-week range for Itoco?

Over the past 52 weeks, Itoco has traded between $0.00 and $0.09.

How much debt does Itoco have?

As of the most recent reporting period, Itoco reported total debt of $220.33K.

How much cash does Itoco have on hand?

Itoco reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Itoco’s dividend yield?

Itoco does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.